24小时热门版块排行榜

>论坛更新日志 (2606)
>虫友互识 (529)
>导师招生 (115)
>休闲灌水 (115)
>文献求助 (113)
>考博 (109)
>教师之家 (62)
>博后之家 (61)
>找工作 (61)
>硕博家园 (57)
>论文投稿 (56)
>论文道贺祈福 (55)
>基金申请 (52)
>考研 (44)
>公派出国 (40)
>招聘信息布告栏 (29)

返回列表

nowinding

铁虫 (小有名气)

应助: 0 (幼儿园)
金币: 221.8
帖子: 95
在线: 36.1小时
虫号: 771553
注册: 2009-05-16
性别: GG
专业: 创新管理

[求助] 求书探讨新药研发新模式的专著一本

书名：Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company
作者：David Cavalla

简介:
The twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R&D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small "biotechnology" companies and "research boutiques," and possibly even the "virtual research company" might play as contractors and collaborators.
章节:
The Pharmaceutical Development Process.

The Advantages of Contracts and Collaborations.

The Disadvantages of Contracts and Collaborations.

The Role of Academic Institutes.

The Role of CROs and Small Research Companies.

Towards the Virtual Research Company.

References.

Index.